Clinical Trials Directory

Trials / Terminated

TerminatedNCT05781672

Prediction of Delayed Toxic Cardiomyopathy in Children

Longitudinal Analysis of Myocardial Function by Speckle Tracking Echocardiography and Prediction of Delayed Toxic Cardiomyopathy Associated With Anthracycline Therapy in Children

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
134 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
11 Years – 27 Years
Healthy volunteers
Accepted

Summary

Longitudinal analysis of myocardial function using "Speckle Tracking Echocardiography" STE analysis and prediction of delayed toxic induced cardiomyopathy in young patients who received anthracycline therapy in childhood.

Detailed description

Anthracycline therapy may have short-, medium- or long-term cardiac toxicity that impacts patient's life. The main recognized risk factors for delayed cardiotoxicity are cumulative anthracycline dose, female gender, association with mediastinal radiotherapy and young age at administration. Prediction of delayed cardiotoxicity in children population is still challenging. The "Speckle Tracking Echocardiography" (STE) method, an innovative echocardiographic technique, analyses the myocardial displacement of natural acoustic markers via a software. The objective of the study is to analyze, in young patients who received anthracycline therapy in childhood, 5-years after their inclusion in the "Speckle Anthra" study and first STE results, the evolution of myocardial function using STE method.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTcardiac ultrasound with speckle tracking analysisExperimental group: cardiac ultrasound with speckle tracking analysis done during a regular cardiac visit planned after receiving cardiotoxic chemotherapy in childhood. Control group: cardiac ultrasound with speckle tracking analysis done during a cardiac visit for minor symptoms (murmur, physical aptitude). Advocated Tomtec software will be used to make post-processing speckle tracking analysis based on 2D ultrasound cineloop acquired during a standard echocardiography.

Timeline

Start date
2023-03-16
Primary completion
2025-01-07
Completion
2025-01-07
First posted
2023-03-23
Last updated
2025-02-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05781672. Inclusion in this directory is not an endorsement.